Gray Cameron 4
4 · Cue Biopharma, Inc. · Filed Jan 5, 2022
Insider Transaction Report
Form 4
Gray Cameron
Director
Transactions
- Award
Stock Option (right to buy)
2022-01-03+10,000→ 10,000 totalExercise: $12.28Exp: 2032-01-02→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy.
- [F2]This option was granted on January 3, 2022. The shares underlying the option are scheduled to vest in full on the anniversary of the grant date.